kallikrein B1
آخر تحديث 18 Aug 2020
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- Ask Patient
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
ال KLKB1 gene provides instructions for making a protein called prekallikrein. Prekallikrein is produced in the liver and circulates in the blood. A molecule called factor XII converts prekallikrein to another protein called plasma kallikrein, and plasma kallikrein helps turn on (activate) more factor XII. Plasma kallikrein and factor XII are involved in the early stages of blood clotting as part of a process called the intrinsic coagulation pathway (also called the contact activation pathway). Blood clots protect the body after an injury by sealing off damaged blood vessels and preventing further blood loss.
اختيارات الفيديو لـ Genesمكتبة الفيديو
Normal function
ال KLKB1 gene provides instructions for making a protein called prekallikrein. Prekallikrein is produced in the liver and circulates in the blood. A molecule called factor XII converts prekallikrein to another protein called plasma kallikrein, and plasma kallikrein helps turn on (activate) more factor XII. Plasma kallikrein and factor XII are involved in the early stages of blood clotting as part of a process called the intrinsic coagulation pathway (also called the contact activation pathway). Blood clots protect the body after an injury by sealing off damaged blood vessels and preventing further blood loss.
The interaction between plasma kallikrein and factor XII also initiates a series of chemical reactions resulting in the release of a protein called bradykinin. Bradykinin promotes inflammation by increasing the permeability of blood vessel walls, allowing more fluids to leak into body tissues. This leakage causes the swelling that accompanies inflammation.
Conditions referring to this gene or chromosome
Other names
Fletcher factor
kallikrein B, plasma (Fletcher factor) 1
kininogenin
plasma kallikrein
plasma kallikrein preproprotein
plasma prekallikrein
PPK
Related patient information and medicines

Patient information leaflet
انسحاب الكحول وإزالة السموم من الكحول
So you will still need willpower and coping strategies for when you feel tempted to drink. Vitamin supplements You are likely to be prescribed vitamins, particularly vitamin B1 (thiamine), if you are alcohol-dependent - especially during 'detox'. This is because many people who are dependent on alcohol do not eat properly and can lack certain.

Patient information leaflet
لدغات ولسعات الحشرات
A compl... Where midges are common, some people wear these when out - for example, when camping next to lakes and rivers. Many camping shops sell them. There is no evidence that eating garlic, vitamin B1 or other الأطعمة will repel insects. Tick bites The tick usually clings to the skin. Remove the tick as soon as possible after the bite, using fine.

Patient information leaflet
متلازمة إعادة التغذية
متلازمة إعادة التغذية was first described in Far East prisoners after the second world wa... Refeeding syndrome is a dangerous and life threatening shift of fluids and body salts (electrolytes) that can occur when malnourished patients receive treatment with refeeding. These shifts cause serious complications such as low body phosphate, abnormal.

Patient information leaflet
اعتلال عضلة القلب التوسعي
Some other chemicals, pesticides and recreational drugs (such as cocaine) have also been shown to weaken the heart muscle and cause dilated cardiomyopathy. Poor diet Being deficient in certain vitamins and minerals, especially vitamin B1 (thiamine), can weaken the heart muscle and lead to dilated cardiomyopathy. This is more common in poorer.

Patient information leaflet
هل يمكنني تناول مخلب الشيطان ومركب فيتامين ب معًا؟
لا توجد no known significant interactions between devil's claw and a standard vitamin B complex supplement. لماذا يحدث هذا Devil's claw and B vitamins are processed by the body through different pathways. Devil's claw is primarily used for its anti-inflammatory properties, while B vitamins act as essential nutrients for energy and cell.

Patient information leaflet
الهزات
Parkinson's disease Tremor is one of the three 'key features' of Parkinson's disease, Parkinson's disease although it doesn't always happen. When it does, it t... In fact, tremor is usually a relatively late symptom, and the average time from diagnosis of MS to developing tremor is 11 years. Vitamins and minerals Vitamin deficiency, particularly.
قراءة إضافية ومراجع
- kallikrein B1; MedlinePlus, National Library of Medicine.
- Bjorkqvist J, Jamsa A, Renne T. Plasma kallikrein: the bradykinin-producing enzyme. Thromb Haemost. 2013 Sep;110(3):399-407. doi: 10.1160/TH13-03-0258. Epub 2013 Jul 11.
- Feener EP, Zhou Q, Fickweiler W. Role of plasma kallikrein in diabetes and metabolism. Thromb Haemost. 2013 Sep;110(3):434-41. doi: 10.1160/TH13-02-0179. Epub 2013 May 16.
- Francois D, Trigui N, Leterreux G, Flaujac C, Horellou MH, Mazaux L, Vignon D, Conard J, de Mazancourt P. Severe prekallikrein deficiencies due to homozygous C529Y mutations. Blood Coagul Fibrinolysis. 2007 Apr;18(3):283-6. doi: 10.1097/MBC.0b013e328010bcde.
- Girolami A, Scarparo P, Candeo N, Lombardi AM. Congenital prekallikrein deficiency. Expert Rev Hematol. 2010 Dec;3(6):685-95. doi: 10.1586/ehm.10.69.
- Lombardi AM, Sartori MT, Cabrio L, Fadin M, Zanon E, Girolami A. Severe prekallikrein (Fletcher factor) deficiency due to a compound heterozygosis (383Trp stop codon and Cys529Tyr). Thromb Haemost. 2003 Dec;90(6):1040-5. doi: 10.1160/TH03-05-0275.
- Nakao T, Yamane T, Katagami T, Shiota M, Izumi Y, Samori T, Hino M, Iwao H. Severe prekallikrein deficiency due to a homozygous Trp499Stop nonsense mutation. Blood Coagul Fibrinolysis. 2011 Jun;22(4):337-9. doi: 10.1097/MBC.0b013e3283444ddb.
- Schmaier AH, McCrae KR. The plasma kallikrein-kinin system: its evolution from contact activation. J Thromb Haemost. 2007 Dec;5(12):2323-9. doi: 10.1111/j.1538-7836.2007.02770.x. Epub 2007 Sep 19.
- Wynne Jones D, Russell G, Allford SL, Burdon K, Hawkins GA, Bowden DW, Minaee S, Mumford AD. Severe prekallikrein deficiency associated with homozygosity for an Arg94Stop nonsense mutation. Br J Haematol. 2004 Oct;127(2):220-3. doi: 10.1111/j.1365-2141.2004.05180.x.
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
18 Aug 2020 | أحدث إصدار
1 Jul 2014 | نُشر في الأصل
شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.
اشترك في النشرة الإخبارية للمرضى
جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.

